| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |